主管单位:中华人民共和国
国家卫生健康委员会
主办单位:中国医师协会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Gao Lei1 Liu Xiaowei1 Wang Jiandong2
单位:1首都医科大学附属北京妇产医院北京妇幼保健院围产医学部,北京100026;2首都医科大学附属北京妇产医院北京妇幼保健院妇瘤科,北京100026
英文单位:1Department of Perinatal Medicine Beijing Obstetrics and Gynecology Hospital Capital Medical University Beijing Maternal and Child Health Care Hospital Beijing 100026 China; 2Department of Gynecologic Oncology Beijing Obstetrics and Gynecology Hospital Capital Medical University Beijing Maternal and Child Health Care Hospital Beijing 100026 China
关键词:未足月胎膜早破;不良妊娠结局;妊娠期糖尿病;生殖道感染;期待治疗时间
英文关键词:Pretermprematureruptureofmembranes;Adversepregnancyoutcomes;Gestationaldiabetesmellitus;Reproductivetractinfection;Expectanttreatmentduration
目的 分析小孕龄未足月胎膜早破(PPROM)孕妇发生不良妊娠结局的影响因素。方法 选取2016年1月至2020年12月首都医科大学附属北京妇产医院收治的276例孕20~27+6周PPROM孕妇作为研究对象,均接受期待保胎治疗,并随访至妊娠结束。依据孕妇是否发生不良妊娠结局分为发生组(193例)与未发生组(83例),比较2组孕妇基线资料,采用Logistic回归模型分析PPROM孕妇发生不良妊娠结局的影响因素。结果 276例PPROM孕妇中发生不良妊娠结局193例,发生率为69.9%。发生组合并妊娠期糖尿病、生殖道感染比例高于未发生组,胎膜早破孕周小于未发生组,期待治疗时间长于未发生组,差异均有统计学意义(均P<0.05)。多因素Logistic回归分析结果显示,合并妊娠期糖尿病(比值比=4.428,95%置信区间:1.191~16.462,P=0.026)、合并生殖道感染(比值比=2.734,95%置信区间:1.074~6.961,P=0.035)、期待治疗时间长(比值比=1.200,95%置信区间:1.106~1.301,P<0.001)均是小孕龄PPROM孕妇发生不良妊娠结局的独立危险因素,胎膜早破孕周晚(比值比=0.689,95%置信区间:0.602~0.788,P<0.001)是独立保护因素。结论 小孕龄PPROM孕妇不良妊娠结局发生率较高,妊娠期糖尿病、生殖道感染、期待治疗时间长是小孕龄PPROM孕妇发生不良妊娠结局的独立危险因素,胎膜早破孕周晚是独立保护因素。
Objective To analyze the influencing factors of adverse pregnancy outcomes in pregnant women with small gestational age preterm premature rupture of membranes (PPROM). Methods From January 2016 to December 2020, 276 pregnant women at 20-27+6 gestational weeks with PPROM admitted to Beijing Obstetrics and Gynecology Hospital, Capital Medical University were selected. All of them received expectant fetal protection treatment and were followed-up to the end of pregnancy. According to whether the pregnant women had adverse pregnancy outcomes, they were divided into the occurrence group (193 cases) and the non-occurrence group (83 cases). Baseline data of pregnant women in the two groups were collected and compared. Logistic regression model was used to analyze the influencing factors of adverse pregnancy outcomes in pregnant women with PPROM. Results Among 276 cases of pregnant women with PPROM, 193 cases had adverse pregnancy outcomes, and the incidence was 69.9%. The proportions of combined gestational diabetes mellitus and combined reproductive tract infections in the occurrence group were higher than those in the non-occurrence group, the gestational week of premature rupture of membranes in the occurrence group was smaller than that in the non-occurrence group, the expectant treatment duration in the occurrence group was longer than that in the non-occurrence group, and the differences were statistically significant (all P<0.05). Multivariate Logistic regression analysis showed that combined with gestational diabetes mellitus (odds ratio=4.428, 95% confidence interval: 1.191-16.462, P=0.026), combined with reproductive tract infections (odds ratio=2.734, 95% confidence interval: 1.074-6.961, P=0.035) and long expectant treatment duration (odds ratio=1.200, 95% confidence interval: 1.106-1.301, P<0.001) were independent risk factors for adverse pregnancy outcomes in pregnant women with small gestational age PPROM, and late gestational week of premature rupture of membranes (odds ratio=0.689, 95% confidence interval: 0.602-0.788,P<0.001) was an independent protective factor. Conclusions The incidence of adverse pregnancy outcomes is high in pregnant women with small gestational age PPROM. Gestational diabetes mellitus, reproductive tract infection and long expectant treatment duration are risk factors for adverse pregnancy outcomes in pregnant women with small gestational age PPROM, and late gestational week of premature rupture of membranes is an independent protective factor.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。